Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-SLV187 (LCIG) Monotherapy in Advanced Parkinson's Disease
NCT01960842Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levodopa + carbidopa in Parkinson's disease (PD), sponsored by AbbVie Inc.. Started Oct 2013; status: completed.
02
Drugs
levodopa + carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01960842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01960842.